Medicon was the first private company operating in the field of medicine in the former Yugoslavia, while today, 30 years later, it has become synonymous with the highest quality products, reliability of service and the support that it provides to partners and patients
This company developed in the dialysis field together with healthcare institutions from the very outset, particularly in supplying dialysis machines and providing for their maintenance and servicing. Similarly, in the field of transfusion, Medicon represents the highest quality products to ensure that patients receive safe blood and blood products.
You started working during years that were difficult for the development of business, but that did not stop you from achieving your objectives. How would you describe the journey that began back in 1992?
— Developing the business during the ’90s was a major challenge that included lots of investment and sacrifice – not only financial, but also in terms of commitment in every sense of the word.
The specificity of our country’s geopolitical and economic position created challenging conditions during those years, and particularly when it came to providing a high-quality level of available medical procedures for extremely vulnerable patients. We are extremely proud of the fact that, despite the circumstances, we created a company that still operates successfully in the domain of medicine and in the same field of indications from its beginnings, until today. We still face many obstacles on our development path today, and we really strive to make sure that the quality of the products and services that we offer represents the strongest tool for preserving and developing our business.
Unlike other companies that have branched out into multiple areas, you focus solely on dialysis and transfusion. Is this the best way to secure continued reliability, quality and trust, which are the most important elements?
— The trust of our users and continuity in our work are our goals, and that is the only way we can offer a really high-quality and complete treatment to patients whose lives depend on these medical procedures. The well-deserved trust that we have gained is a result of many years of cooperation, the highest quality products and the reliability of the services and support that we offer.
Our focus remains directed towards areas of chronic and acute dialysis, including water treatment, as well as towards the area of transfusion
Today, just as in our infancy, our focus remains directed towards areas of chronic and acute dialysis, including water treatment, as well as towards the area of transfusion. In this way we are able to direct all our financial resources, knowhow, development and expansion of our team, to these two areas of medicine and thereby maintain the highest level of our business operations.
Do you believe that the development of technology and the latest scientific achievements will enable you to bring healing to patients, or at least a better quality of life, and better working conditions to healthcare workers?
— The development of technology and scientific achievements contribute to the development of medicine, and all with the aim of securing a better quality of life for patients. This is one of the reasons why Medicon remains faithful to the companies it represents from day one, companies that have always been pioneers in coming up with solutions that are innovative and cutting-edge in terms of technology. These are companies that have spent decades investing in technology research and development and have the highest level of production quality control, but also control and monitoring of market placements and monitoring quality with end users on the basis of recommendations and in accordance with European and world standards. Of course, developing technology also creates better working conditions for healthcare workers, as well as significantly reducing the possibility of human error when using devices.
